Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production

Y Yamada1, K Sugahara, K Tsuruda

  • 1Department of Laboratory Medicine, Nagasaki University School of Medicine, Japan.

Cancer Letters
|February 5, 2000
PubMed

Insights

Human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) do not appear to directly cause Fas resistance in adult T-cell leukemia (ATL) cells. Increased HTLV-I production or FAP-1 was not observed in Fas-resistant ATL cell lines.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) have been implicated in preventing Fas-mediated apoptosis in infected cells.
  • Adult T-cell leukemia (ATL) is an aggressive malignancy associated with HTLV-I infection.

Purpose of the Study:

  • To investigate whether increased production of HTLV-I or FAP-1 is associated with the development of Fas resistance in ATL cell lines.
  • To determine the role of HTLV-I and FAP-1 in Fas-mediated apoptosis resistance in ATL.

Main Methods:

  • Comparison of HTLV-I production and FAP-1 mRNA levels in Fas-sensitive and Fas-resistant ATL cell lines.
  • Analysis of Fas sensitivity in ATL cell lines and their subclones.

Main Results:

  • Fas-resistant ATL cell line subclones (RSO4, RST1) produced equivalent amounts of HTLV-I compared to their Fas-sensitive counterparts (SO4, ST1).
  • FAP-1 mRNA was not detected in any of the tested ATL cell lines, regardless of their Fas sensitivity.
  • Fas resistance in ATL cells was not directly correlated with increased HTLV-I production or FAP-1 expression.

Conclusions:

  • The acquisition of Fas resistance in ATL cells is not directly mediated by increased HTLV-I production or FAP-1 expression.
  • These findings suggest alternative mechanisms contribute to Fas resistance in ATL pathogenesis.

Related Concept Videos